Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Pharmacol., 03 December 2025

Sec. Respiratory Pharmacology

Volume 16 - 2025 | https://doi.org/10.3389/fphar.2025.1751855

Correction: The role of TGF-β1 in chronic multilobar segmental bronchial stenosis and advances in targeted drug research

This article is a correction to:

  1. The role of TGF-β1 in chronic multilobar segmental bronchial stenosis and advances in targeted drug research

    1. Read original article
Mingjun Wu,&#x;Mingjun Wu1,2†Qian Yang,&#x;Qian Yang2,3†Youcheng Xie,&#x;Youcheng Xie1,2†Yan Hou, Yan Hou1,2*Qingliang Xue, Qingliang Xue1,2*
  • 1Department of Respiratory and Critical Care Medicine, 940th Hospital of Joint Logistic Support Force of Chinese People’s Liberation Army, Lanzhou, Gansu, China
  • 2Department of Plateau Medicine, 940th Hospital of Joint Logistic Support Force of Chinese People’s Liberation Army, Lanzhou, Gansu, China
  • 3Central Sterile Supply Department, 940th Hospital of Joint Logistic Support Force of Chinese People’s Liberation Army, Lanzhou, Gansu, China

A Correction on
The role of TGF-β1 in chronic multilobar segmental bronchial stenosis and advances in targeted drug research

by Wu M, Yang Q, Xie Y, Hou Y and Xue Q (2025). Front. Pharmacol. 16:1649570. doi: 10.3389/fphar.2025.1649570

An incorrect number was provided for the Lanzhou Science and Technology Plan Project. The correct number is 2024-9-167.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: chronic multilobar segmental bronchial stenosis, transforming growth factor-β1, Smad signaling pathway, targeted therapy, airway remodeling

Citation: Wu M, Yang Q, Xie Y, Hou Y and Xue Q (2025) Correction: The role of TGF-β1 in chronic multilobar segmental bronchial stenosis and advances in targeted drug research. Front. Pharmacol. 16:1751855. doi: 10.3389/fphar.2025.1751855

Received: 22 November 2025; Accepted: 25 November 2025;
Published: 03 December 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Wu, Yang, Xie, Hou and Xue. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yan Hou, aG91eWFuMDgwN0Bob3RtYWlsLmNvbQ==; Qingliang Xue, MTUwMDI1MjA0OTdAMTYzLmNvbQ==

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.